BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12168082)

  • 1. Genetic alterations related to lymph node metastasis and peritoneal dissemination in epithelial ovarian cancers.
    Umayahara K; Numa F; Inokuma A; Sueoka K; Kawasaki K; Hirakawa H; Emoto T; Sakaguchi Y; Nawata S; Ogata H; Sakamoto M; Hasumi K; Kawauchi S; Sasaki K; Kato H
    Oncol Rep; 2002; 9(5):1115-9. PubMed ID: 12168082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer.
    Hidaka S; Yasutake T; Kondo M; Takeshita H; Yano H; Haseba M; Tsuji T; Sawai T; Nakagoe T; Tagawa Y
    Anticancer Res; 2003; 23(4):3353-7. PubMed ID: 12926075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genomic changes in primary lesion and lymph node metastases of esophageal squamous cell carcinoma].
    Qin YR; Wang LD; Dora K; Guan XY; Zhuang ZH; Fan ZM; Deng W; Cao SH
    Ai Zheng; 2005 Sep; 24(9):1048-53. PubMed ID: 16159423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-pathologic evaluation of retroperitoneal lymph node metastasis in ovarian carcinoma].
    Takahashi Y; Chiba T; Inaba S; Yamamoto A; Nomura T; Yamamoto Y; Kasahara K; Tenzaki T; Ishiguro T; Yoshida Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1489-94. PubMed ID: 2273303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers.
    Li C; Liu J; Lu R; Yu G; Wang X; Zhao Y; Song H; Lin P; Sun X; Yu X; Zhang Y; Ning X; Geng J
    Int J Gynecol Cancer; 2011 May; 21(4):602-8. PubMed ID: 21543927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer.
    Ghadimi BM; Grade M; Liersch T; Langer C; Siemer A; Füzesi L; Becker H
    Clin Cancer Res; 2003 May; 9(5):1808-14. PubMed ID: 12738738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
    Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
    Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
    Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma.
    Staebler A; Karberg B; Behm J; Kuhlmann P; Neubert U; Schmidt H; Korsching E; Bürger H; Lelle R; Kiesel L; Böcker W; Shih IeM; Buchweitz O
    Genes Chromosomes Cancer; 2006 Oct; 45(10):905-17. PubMed ID: 16845658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
    Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis.
    Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis by comparative genomic hybridization of gastric cancer with peritoneal dissemination and/or positive peritoneal cytology.
    Morohara K; Nakao K; Tajima Y; Nishino N; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Kawamura M; Aida T; Tachikawa T; Kusano M
    Cancer Genet Cytogenet; 2005 Aug; 161(1):57-62. PubMed ID: 16080958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
    Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
    Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways.
    Noutomi Y; Oga A; Uchida K; Okafuji M; Ita M; Kawauchi S; Furuya T; Ueyama Y; Sasaki K
    J Pathol; 2006 Sep; 210(1):67-74. PubMed ID: 16767698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of peritoneal fluid in ovarian cancer patients.
    Parrella P; Zangen R; Sidransky D; Nicol T
    Mod Pathol; 2003 Jul; 16(7):636-40. PubMed ID: 12861058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analyses of primary and metastatic serous epithelial ovarian cancer.
    Israeli O; Gotlieb WH; Friedman E; Korach J; Friedman E; Goldman B; Zeltzer A; Ben-Baruch G; Rienstein S; Aviram-Goldring A
    Cancer Genet Cytogenet; 2004 Oct; 154(1):16-21. PubMed ID: 15381367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma.
    Bruchim I; Israeli O; Mahmud SM; Aviram-Goldring A; Rienstein S; Friedman E; Ben-Baruch G; Gotlieb WH
    Cancer Genet Cytogenet; 2009 Apr; 190(2):66-70. PubMed ID: 19380021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of early- versus late-stage ovarian tumors.
    Shridhar V; Lee J; Pandita A; Iturria S; Avula R; Staub J; Morrissey M; Calhoun E; Sen A; Kalli K; Keeney G; Roche P; Cliby W; Lu K; Schmandt R; Mills GB; Bast RC; James CD; Couch FJ; Hartmann LC; Lillie J; Smith DI
    Cancer Res; 2001 Aug; 61(15):5895-904. PubMed ID: 11479231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
    Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.